Cas:195833-47-7 (2S)-2-prop-2-enylpyrrolidine-2-carboxylic acid manufacturer & supplier

We serve Chemical Name:(2S)-2-prop-2-enylpyrrolidine-2-carboxylic acid CAS:195833-47-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2S)-2-prop-2-enylpyrrolidine-2-carboxylic acid

Chemical Name:(2S)-2-prop-2-enylpyrrolidine-2-carboxylic acid
CAS.NO:195833-47-7
Synonyms:2-(2-propenyl)-d-proline
Molecular Formula:C8H13NO2
Molecular Weight:155.19400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:49.33000
Exact Mass:155.09500
LogP:1.09810

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(2-propenyl)-d-proline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2-propenyl)-d-proline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2-propenyl)-d-proline Use and application,2-(2-propenyl)-d-proline technical grade,usp/ep/jp grade.


Related News: Earlier this year, the company revealed it had broken ground on a 38,000-square-foot commercial cell therapy plant in Lexington, Massachusetts, which is about 10 miles from downtown Boston. Takeda says the new $84 million plant will be used to make cell therapies for cancers and other diseases. 3-{3-[(2-bromo-ethylamino)-methyl]-4-hydroxy-phenyl}-2-methyl-3H-quinazolin-4-one manufacturers He further explained that getting a new drug to commercial manufacturing is also complex and costly due to the very stringent drug manufacturing regulatory mechanism. [5-(2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-3a,5,6, 6a-tetrahydrofuro[4,5-d][1,3]dioxol-6-yl] benzenesulfonate suppliers Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. 2,3,4-TRI-O-ACETYL-α-D-ARABINOPYRANOSYL BROMIDE vendor & factory.